Dr. Maria I. Quejada

Hematology Oncology | Hematology | Oncology
801 S Washington St, 
Naperville, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
801 S Washington St, 
Naperville, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Maria Quejada is a Hematologist Oncology specialist and a Hematologist in Naperville, Illinois. Dr. Quejada is rated as an Experienced provider by MediFind in the treatment of Leukocytosis. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Quejada is currently accepting new patients.

Her clinical research consists of co-authoring 1 peer reviewed article and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in IL
Hospital Affiliations
Elmhurst Memorial Hospital
Swedish Hospital
Edward Hospital
Languages Spoken
English
Filipino
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

ENDEAVOR HEALTH MEDICAL GROUP
801 S Washington St, Naperville, IL 60540
Other Locations
ENDEAVOR HEALTH MEDICAL GROUP
120 Spalding Dr, Suite 205and207, Naperville, IL 60540
ENDEAVOR HEALTH MEDICAL GROUP
2650 Ridge Ave, Evanston, IL 60201
ENDEAVOR HEALTH MEDICAL GROUP
24600 W 127th St, Plainfield, IL 60585

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Enrollment Status: Recruiting
Publish Date: July 03, 2024
Intervention Type: Other, Drug
Study Drug: Crizotinib
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
EA5163/S1709 INSIGNA : A Randomized, Phase III Study of Firstline Immunotherapy Alone or in Combination With Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) With Immunobiomarker SIGNature-Driven Analysis
EA5163/S1709 INSIGNA : A Randomized, Phase III Study of Firstline Immunotherapy Alone or in Combination With Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) With Immunobiomarker SIGNature-Driven Analysis
Enrollment Status: Active_not_recruiting
Publish Date: November 25, 2025
Intervention Type: Procedure, Drug, Biological
Study Drugs: Carboplatin, Pembrolizumab, Pemetrexed
Study Phase: Phase 3
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer
An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-small Cell Lung Cancer (NSCLC)
A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: August 05, 2019
Intervention Type: Drug, Radiation
Study Phase: Phase 2
View 6 Less Clinical Trials

1 Total Publications

Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer.
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer.
Journal: Journal for immunotherapy of cancer
Published: September 07, 2021
Similar Doctors
Distinguished in Leukocytosis
Dr. Olusola O. Ogundipe
Hematology Oncology | Hematology | Oncology
Distinguished in Leukocytosis
Dr. Olusola O. Ogundipe
Hematology Oncology | Hematology | Oncology

Northwest Cancer Centers PC

342 E 109th Ave, Northwest Cancer Ctr, 
Crown Point, IN 
 (48.6 miles away)
219-310-2550
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Olusola Ogundipe is a Hematologist Oncology specialist and a Hematologist in Crown Point, Indiana. Dr. Ogundipe is rated as a Distinguished provider by MediFind in the treatment of Leukocytosis. His top areas of expertise are Myelodysplastic Syndrome (MDS), Leukocytosis, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Ogundipe is currently accepting new patients.

Distinguished in Leukocytosis
Dr. Nida Hussain
Hematology | Oncology
Distinguished in Leukocytosis
Dr. Nida Hussain
Hematology | Oncology
4405 Weaver Pkwy, 
Waterman, IL 
 (4.4 miles away)
815-334-5566
Experience:
13+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nida Hussain is a Hematologist and an Oncologist in Waterman, Illinois. Dr. Hussain has been practicing medicine for over 13 years and is rated as an Advanced provider by MediFind in the treatment of Leukocytosis. Her top areas of expertise are Leukocytosis, Non-Small Cell Lung Cancer (NSCLC), ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma.

Katy H. Goldsborough
Distinguished in Leukocytosis
Dr. Katy H. Goldsborough
Hematology | Oncology
Distinguished in Leukocytosis
Dr. Katy H. Goldsborough
Hematology | Oncology

Advocate Good Samaritan Cancer Center

3745 Highland Ave 2nd Fl, 
Downers Grove, IL 
 (7.6 miles away)
630-275-2300
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Katy Goldsborough is a Hematologist and an Oncologist in Downers Grove, Illinois. Dr. Goldsborough is rated as an Advanced provider by MediFind in the treatment of Leukocytosis. Her top areas of expertise are Breast Cancer, Leukocytosis, Paget Disease of the Breast, and Pleuropulmonary Blastoma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Quejada's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 15 Advanced Conditions
    View All 106 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile